DENRAKIBART
UNII 4K7FCQ266Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Denrakibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4K7FCQ266Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2922866-66-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4K7FCQ266Q
CAS Registry Number
2922866-66-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DENRAKIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C211732
National Cancer Institute reference terminology for clinical and research data.
INN ID
13177
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Denrakibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DENRAKIBART

Common Names & Synonyms

DENRAKIBART [INN]
H-GAMMA2 HEAVY CHAIN HOMO SAPIENS (1-447) (VH (HOMO SAPIENS IGHV5-51*01 (98.0%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.14) (26-33.51-58.97-110)) (1-121) -HOMO SAPIENS IGHG2*01 G2M.. CH2 V45.1, G2V3 CH2 A1.2, A1, S2, A30, L92, S115, S116 (CH1 P92>T (193) (122-219), HINGE 1-12 (220-231), CH2 V1.2>A (235), G1>A (237), P2>S (238), H30>A (268), V45.1 (282), V92>L (309), A115>S (330), P116>S(331) (232-340), CH3 (341-445), CHS (446-447)) (341-447)), (135-220')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-220') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (92.1%) -IGKJ1*01 (100%), CDR-IMGT (12.3.9) (27'-38'.56'-58'.95'-103')) (1'-113') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (159'), V101 (197')) (114'-220')); DIMER (223-223'':224-224'':227-227'':230-230'')-TETRAKISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV, GLYCOFORM ALFA
IMMUNOGLOBULIN G2, ANTI-(HUMAN CC CHEMOKINE CCL17) (RECOMBINANT HUMAN MONOCLONAL GSK3858279 .GAMMA.2-CHAIN), DISULFIDE WITH RECOMBINANT HUMAN MONOCLONAL GSK3858279 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G2-KAPPA, ANTI-(HOMO SAPIENS CCL17 (C-C MOTIF CHEMOKINE LIGAND 17, CHEMOKINE (C-C MOTIF) LIGAND 17, SMALL INDUCIBLE CYTOKINE SUBFAMILY A (CYS-CYS) MEMBER 17, SCYA17, THYMUS AND ACTIVATION-REGULATED CHEMOKINE, TARC)), HOMO SAPIENS MONOCLONAL ANTIBODY

Technical Codes

GSK3858279
GSK-3858279

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus